Wordt geladen...
Second line (disease modifying) treatment in rheumatoid arthritis: which drug for which patient?
OBJECTIVES--The objectives were to assess (a) the comparative merits of commonly used disease modifying drugs in the treatment of rheumatoid arthritis (RA) and (b) the influence of age, gender, and disease duration on the outcome of treatment. METHODS--Collected analysis (meta-analysis) was performe...
Bewaard in:
| Gepubliceerd in: | Ann Rheum Dis |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMJ Publishing Group
1993
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1005066/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8100702/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.52.6.423 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|